Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life
- PMID: 28783450
- PMCID: PMC5648174
- DOI: 10.1200/JCO.2017.72.7149
Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life
Abstract
Purpose Little is known about the patterns and predictors of the use of end-of-life health care among patients with acute myeloid leukemia (AML). End-of-life care is particularly relevant for older adults with AML because of their poor prognosis. Methods We performed a population-based, retrospective cohort study of patients with AML who were ≥ 66 years of age at diagnosis and diagnosed during the period from 1999 to 2011 and died before December 31, 2012. Medicare claims were used to assess patterns of hospice care and use of aggressive treatment. Predictors of these end points were evaluated using multivariable logistic regression analyses. Results In the overall cohort (N = 13,156), hospice care after AML diagnosis increased from 31.3% in 1999 to 56.4% in 2012, but the increase was primarily driven by late hospice enrollment that occurred in the last 7 days of life. Among the 5,847 patients who enrolled in hospice, 47.4% and 28.8% started their first hospice enrollment in the last 7 and 3 days of life, respectively. Among patients who transferred in and out of hospice care, 62% received transfusions outside hospice. Additionally, the use of chemotherapy within the last 14 days of life increased from 7.7% in 1999 to 18.8% in 2012. Patients who were male and nonwhite were less likely to enroll in hospice and more likely to receive chemotherapy or be admitted to intensive care units at the end of life. Conversely, older patients were less likely to receive chemotherapy or have intensive care unit admission at the end of life, and were more likely to enroll in hospice. Conclusion End-of-life care for older patients with AML is suboptimal. Additional research is warranted to identify reasons for their low use of hospice services and strategies to enhance end-of-life care for these patients.
Figures
Similar articles
-
Family Perspectives on Aggressive Cancer Care Near the End of Life.JAMA. 2016 Jan 19;315(3):284-92. doi: 10.1001/jama.2015.18604. JAMA. 2016. PMID: 26784776 Free PMC article.
-
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.Cancer. 2016 Apr 15;122(8):1209-15. doi: 10.1002/cncr.29913. Epub 2016 Feb 23. Cancer. 2016. PMID: 26914833
-
Patterns and predictors of end-of-life care in older patients with pancreatic cancer.Cancer Med. 2018 Dec;7(12):6401-6410. doi: 10.1002/cam4.1861. Epub 2018 Nov 13. Cancer Med. 2018. PMID: 30426697 Free PMC article.
-
Race, Any Cancer, Income, or Cognitive Function: What Inf luences Hospice or Aggressive Services Use at the End of Life Among Community-Dwelling Medicare Beneficiaries?Am J Hosp Palliat Care. 2016 Jul;33(6):537-45. doi: 10.1177/1049909115574263. Epub 2015 Mar 9. Am J Hosp Palliat Care. 2016. PMID: 25753184 Free PMC article. Review. No abstract available.
-
Hospice as an alternative model of care for older patients with end-stage heart failure.J Cardiovasc Nurs. 2004 Jan-Feb;19(1):76-83; quiz 84-5. doi: 10.1097/00005082-200401000-00012. J Cardiovasc Nurs. 2004. PMID: 14994785 Review.
Cited by
-
Perspectives on Transfusions for Hospice Patients With Blood Cancers: A Survey of Hospice Providers.J Pain Symptom Manage. 2024 Jan;67(1):1-9. doi: 10.1016/j.jpainsymman.2023.09.024. Epub 2023 Sep 29. J Pain Symptom Manage. 2024. PMID: 37777022
-
Access to High-Quality Hospice Care in a For-Profit World.Oncologist. 2023 Sep 7;28(9):743-745. doi: 10.1093/oncolo/oyad205. Oncologist. 2023. PMID: 37487057 Free PMC article.
-
Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence.Curr Treat Options Oncol. 2023 May;24(5):542-564. doi: 10.1007/s11864-023-01084-1. Epub 2023 Apr 5. Curr Treat Options Oncol. 2023. PMID: 37017909 Free PMC article. Review.
-
Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.Blood Adv. 2023 May 9;7(9):1871-1884. doi: 10.1182/bloodadvances.2022008996. Blood Adv. 2023. PMID: 36521100 Free PMC article.
-
Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes.J Geriatr Oncol. 2023 Jan;14(1):101374. doi: 10.1016/j.jgo.2022.09.003. Epub 2022 Sep 10. J Geriatr Oncol. 2023. PMID: 36100548 Free PMC article.
References
-
- Xie Y, Davies SM, Xiang Y, et al. : Trends in leukemia incidence and survival in the United States (1973-1998). Cancer 97:2229-2235, 2003 - PubMed
-
- Pulsoni A, Pagano L, Latagliata R, et al. : Survival of elderly patients with acute myeloid leukemia. Haematologica 89:296-302, 2004 - PubMed
-
- Lang K, Earle CC, Foster T, et al. : Trends in the treatment of acute myeloid leukaemia in the elderly. Drugs Aging 22:943-955, 2005 - PubMed
-
- Baz R, Rodriguez C, Fu AZ, et al. : Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia. Cancer 110:1752-1759, 2007 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical